The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Gramont, A., Figer, A., Seymour, M., Homerin, M., Hmissi, A., Cassidy, J., Boni, C., Cortes-Funes, H., Cervantes, A., Freyer, G., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.2938 · Cited by 3,815 · cited 2×
“1 months for combinations of 5-FU and irinotecan (CPT-11) [1–4] or oxaliplatin [5, 6] as first-line treatment for metastatic disease.”
BackgroundDouillard, J., Cunningham, D., Roth, A., Navarro, M., James, R., Karasek, P., Jandik, P., Iveson, T., Carmichael, J., Alakl, M., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02034-1 · Cited by 3,256
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
Saltz, L. B., Cox, J. V., Blanke, C., Rosen, L. S., Fehrenbacher, L., Moore, M. J., Maroun, J. A., Ackland, S. P., Locker, P. K., Pirotta, N., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431302 · Cited by 3,005
Tournigand, C., André, T., Achille, E., Lledo, G., Flesh, M., Mery-Mignard, D., Quinaux, E., Couteau, C., Buyse, M., Ganem, G., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.113 · Cited by 2,915
Giacchetti, S., Perpoint, B., Zidani, R., Le Bail, N., Faggiuolo, R., Focan, C., Chollet, P., Llory, J. F., Letourneau, Y., Coudert, B., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.1.136 · Cited by 1,403
(1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.301 · Cited by 981
Resection of Nonresectable Liver Metastases from Colorectal Cancer After Neoadjuvant Chemotherapy
Bismuth, H., Adam, R., Lévi, F., Farabos, C., Waechter, F., Castaing, D., Majno, P., & Engerran, L. (1996) · Annals of Surgery · doi:10.1097/00000658-199610000-00009 · Cited by 963
WAGNER, J. S., ADSON, M. A., VAN HEERDEN, J. A., ADSON, M. H., & ILSTRUP, D. M. (1984) · Annals of Surgery · doi:10.1097/00000658-198405000-00002 · Cited by 694
Adam, R., Avisar, E., Ariche, A., Giachetti, S., Azoulay, D., Castaing, D., Kunstlinger, F., Levi, F., & Bismuth, F. (2001) · Annals of Surgical Oncology · doi:10.1007/s10434-001-0347-3 · Cited by 657
Scheithauer, W., Rosen, H., Kornek, G. V., Sebesta, C., & Depisch, D. (1993) · BMJ · doi:10.1136/bmj.306.6880.752 · Cited by 654
Giacchetti, S., Itzhaki, M., Gruia, G., Adam, R., Zidani, R., Kunstlinger, F., Brienza, S., Alafaci, E., Bertheault-Cvitkovic, F., Jasmin, C., et al. (1999) · Annals of Oncology · doi:10.1023/a:1008347829017 · Cited by 606
Allen-Mersh, T. G., Earlam, S., Fordy, C., Abrams, K., & Houghton, J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90750-1 · Cited by 534
Meta-Analysis Group In Cancer (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.5.252 · Cited by 441
Long-term survival following resection of colorectal hepatic metastases
Jaeck, D., Bachellier, P., Guiguet, M., Boudjema, K., Vaillant, J. C., Balladur, P., Nordlinger, B., & de Chirurgie, F. (1997) · Journal of British Surgery · doi:10.1002/bjs.1800840719 · Cited by 338
Surgical treatment of liver metastases in patients with colorectal cancer
Ballantyne, G. H., & Quin, J. (1993) · Cancer · doi:10.1002/1097-0142(19930615)71:12+<4252::aid-cncr2820711815>3.0.co;2-6 · Cited by 285
Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases
Adam, R. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg731 · Cited by 238
Nordlinger, B., Vaillant, J. C., Guiguet, M., Balladur, P., Paris, F., Bachellier, P., & Jaeck, D. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.7.1491 · Cited by 224
Falcone, A., Masi, G., Allegrini, G., Danesi, R., Pfanner, E., Brunetti, I. M., Paolo, A. D., Cupini, S., Tacca, M. D., & Conte, P. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.12.075 · Cited by 180
Rivoire, M. L., Cian, F. D., Méeus, P., Négrier, S., Sebban, H., & Kaemmerlen, P. (2002) · Cancer · doi:10.1002/cncr.10973 · Cited by 136
Complications of Hepatic Artery Infusion : A Review of 4580 Reported Cases
Barnett, K. T., & Malafa, M. P. (2001) · International Journal of Gastrointestinal Cancer · doi:10.1385/ijgc:30:3:147 · Cited by 94
Köhne, C.-H., Cutsem, E. V., Wils, J. A., Bokemeyer, C., El-Serafi, M., Lutz, M. P., Lorenz, M., Anak, O., Genicot, B., & Nordlinger, B. (2003) · European Journal of Cancer Supplements · doi:10.1016/s1359-6349(03)91114-1 · Cited by 69
Lygidakis, N. J., Sgourakis, G. G., Dedemadi, G., et al. (2001) · PubMed · Cited by 13
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Falcone, A., Ricci, S., Brunetti, I., Pfanner, E., Allegrini, G., Barbara, C., Crinò, L., Benedetti, G., Evangelista, W., Fanchini, L., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.0928 · Cited by 1,241
“However, although FOLFOX has more data with regard to the capacity to induce resectability in previously unresectable patients, similar results have been reported with FOLFIRI as well.(12) Furthermore, comparisons of FOLFOX with FOLFIRI in randomized studies have reported equivalent activity and efficacy.”
ResultFolprecht, G., Gruenberger, T., Bechstein, W. O., Raab, H.-R., Lordick, F., Hartmann, J. T., Lang, H., Frilling, A., Stoehlmacher, J., Weitz, J., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70330-4 · Cited by 963
Engstrom, P. F., Arnoletti, J. P., Benson, A. B., Chen, Y.-J., Choti, M. A., Cooper, H. S., Covey, A., Dilawari, R. A., Early, D. S., Enzinger, P. C., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0056 · Cited by 683
Folprecht, G., Grothey, A., Alberts, S., Raab, H.-R., & Köhne, C.-H. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi246 · Cited by 632
Metadata
- Authors
- Pozzo, C., Basso, M., Cassano, A., Quirino, M., Schinzari, G., Trigila, N., Vellone, M., Giuliante, F., Nuzzo, G., & Barone, C.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2004-06
- Volume
- 15
- Issue
- 6
- Pages
- 933-939
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2016726396
- Cited by
- 315
- References
- 22
- FWCI
- 11.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.